Literature DB >> 20448437

Endothelial nitric oxide synthase as a marker for human endothelial progenitor cells.

Wei Qiao1, Lingying Niu, Zhao Liu, Tong Qiao, Changjian Liu.   

Abstract

Endothelial progenitor cells (EPCs) have been proposed as a promising tool for therapeutic neovascularization, vascular repair, tumor pathology and tissue engineering, though their identification is still a subject of much discussion. EPCs consist of two different subpopulations, termed endothelial cell (EC)-like cells and endothelial outgrowth cells (EOCs). Both types of EPCs are derived from mononuclear cells, but they have different characteristics. Our aim was to characterize and compare the two types of EPCs to find reliable biological features of EPCs that can be used for identification of EPCs. In this study, human peripheral blood mononuclear cells were isolated by density gradient centrifugation and cultured on fibronectin-coated culture plates. While adherent cells were maintained, EC-like cells appeared within 4-7 days of culture, and EOCs developed after 2-3 weeks of culture. EOCs, which were characterized by high proliferation potential, were able to form capillary tubes on Matrigel, but not EC-like cells, despite the higher concentrations of three angiogenic cytokines, vascular endothelial growth factor, granulocyte colony-stimulating factor, and interleukin 8, in the conditioned medium of EC-like cells. In contrast, endothelial nitric oxide synthase (eNOS) was expressed in both types of EPCs, and both cell types could produce nitric oxide (NO), as judged by measuring the total amounts of nitrites and nitrates in culture media. In conclusion, the expression of eNOS and the production of NO could be used as common biological features to identify EPCs. These findings provide new insights into the identification of EPCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448437     DOI: 10.1620/tjem.221.19

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells.

Authors:  Yu-yan Zhang; Hui-fen Zhou; Jie-hong Yang; Yu He; Xiao-qiang Chen; Katsuyoshi Nishinari; Hao-fang Wan; Hai-tong Wan
Journal:  Chin J Integr Med       Date:  2016-04-09       Impact factor: 1.978

2.  Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.

Authors:  G Mangialardi; A Monopoli; E Ongini; G Spinetti; O Fortunato; C Emanueli; P Madeddu
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Magnetic resonance imaging and immunohistochemistry of primary vertebral hemangiosarcoma in a dog and implications for diagnosis and therapy.

Authors:  Claudia Pérez-Martínez; Marta Regueiro-Purriños; Beatriz Fernández-Martínez; José R Altónaga; José M Gonzalo-Orden; María J García-Iglesias
Journal:  Can Vet J       Date:  2016-12       Impact factor: 1.008

Review 4.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.

Authors:  Shuai Yuan; Christopher G Kevil
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 5.  Endothelial progenitor cells as critical mediators of environmental air pollution-induced cardiovascular toxicity.

Authors:  Parul Singh; Timothy E O'Toole; Daniel J Conklin; Bradford G Hill; Petra Haberzettl
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-19       Impact factor: 4.733

6.  Regulation of c-Jun N-Terminal Protein Kinase (JNK) Pathway in Apoptosis of Endothelial Outgrowth Cells Induced by Asymmetric Dimethylarginine.

Authors:  Fu-Qing Zhang; Wei Lu; Wen-Xiao Yuan; Xin Li
Journal:  Med Sci Monit       Date:  2017-05-26

7.  Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.

Authors:  Yichi Zhang; Ruini Li; Weiwei Rong; Mingzi Han; Chenghu Cui; Zhenning Feng; Xiaoli Sun; Shizhu Jin
Journal:  Cell Death Dis       Date:  2018-12-11       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.